PT  - JOURNAL ARTICLE
AU  - Gholipour, Taha
AU  - DeMarco, Andrew
AU  - You, Xiaozhen
AU  - Englot, Dario J
AU  - Turkeltaub, Peter E
AU  - Koubeissi, Mohamad Z
AU  - Gaillard, William D.
AU  - Morgan, Victoria L
TI  - Functional anomaly mapping lateralizes temporal lobe epilepsy with high accuracy in individual patients
AID  - 10.1101/2023.02.05.23285034
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.02.05.23285034
4099  - http://medrxiv.org/content/early/2023/02/08/2023.02.05.23285034.short
4100  - http://medrxiv.org/content/early/2023/02/08/2023.02.05.23285034.full
AB  - Objective Mesial temporal lobe epilepsy (mTLE) is associated with variable dysfunction beyond the temporal lobe. We used functional anomaly mapping (FAM), a multivariate machine learning approach to resting state fMRI analysis to measure subcortical and cortical functional aberrations in patients with mTLE. We also examined the value of individual FAM in lateralizing the hemisphere of seizure onset in mTLE patients. Methods: Patients and controls were selected from an existing imaging and clinical database. After standard preprocessing of resting state fMRI, time-series were extracted from 400 cortical and 32 subcortical regions of interest (ROIs) defined by atlases derived from functional brain organization. Group-level aberrations were measured by contrasting right (RTLE) and left (LTLE) patient groups to controls in a support vector regression models, and tested for statistical reliability using permutation analysis. Individualized functional anomaly maps (FAMs) were generated by contrasting individual patients to the control group. Half of patients were used for training a classification model, and the other half for estimating the accuracy to lateralize mTLE based on individual FAMs. Results: Thirty-two right and 14 left mTLE patients (33 with evidence of hippocampal sclerosis on MRI) and 94 controls were included. At group levels, cortical regions affiliated with limbic and somatomotor networks were prominent in distinguishing RTLE and LTLE from controls. At individual levels, most TLE patients had high anomaly in bilateral mesial temporal and medial parietooccipital default mode regions. A linear support vector machine trained on 50% of patients could accurately lateralize mTLE in remaining patients (median AUC =1.0 [range 0.97-1.0], median accuracy = 96.87% [85.71-100Significance: Functional anomaly mapping confirms widespread aberrations in function, and accurately lateralizes mTLE from resting state fMRI. Future studies will evaluate FAM as a non-invasive localization method in larger datasets, and explore possible correlations with clinical characteristics and disease course.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work supported by the District of Columbia Intellectual and Developmental Disabilities Research Center (DC-IDDRC, NICHD U54-HD090257). This publication was also supported by Award Number UL1TR001876 from the NIH National Center for Advancing Translational Sciences, and KL2TR001877 to TG. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the NIH. Additional sources of funding: AD: K99 DC018828; DJE: NIH NS097618; MZK: GW Epilepsy Research Fund; and VM: NIH NS075270, NS110130, NS108445.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Vanderbilt University Institutional Review Board approved the use of human subjects for this study and written consent was acquired from all subjects prior to participation. Analysis of anonymized data was approved by the George Washington University Institutional Review Board as exempt.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnonymized data and code will be shared upon request by qualified investigators.